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Stefin B (cystatin B) is an endogenous inhibitor of cysteine proteinases localized
in the nucleus and the cytosol. Loss-of-function mutations in the stefin B gene
(CSTB) gene were reported in patients with Unverricht-Lundborg disease (EPM1).
Our previous results showed that thymocytes isolated from stefin B-deficient mice
are more sensitive to apoptosis induced by the protein kinase C (PKC) inhibitor
staurosporin (STS) than the wild-type control cells. We have also shown that the
increased expression of stefin B in the nucleus of T98G astrocytoma cells delayed
cell cycle progression through the S phase. In the present study we examined if
the nuclear or cytosolic functions of stefin B are responsible for the accelerated
induction of apoptosis observed in the cells from stefin B-deficient mice. We have
shown that the overexpression of stefin B in the nucleus, but not in the cytosol of
astrocytoma T98G cells, delayed caspase-3 and -7 activation. Pretreatment of cells with
the pan-caspase inhibitor z-Val-Ala-Asp(OMe)-fluoromethylketone completely inhibited
caspase activation, while treatment with the inhibitor of calpains- and papain-like
cathepsins (2S,3S)-trans-epoxysuccinyl-leucylamido-3-methyl-butane ethyl ester did not
prevent caspase activation. We concluded that the delay of caspase activation in T98G
cells overexpressing stefin B in the nucleus is independent of cathepsin inhibition.
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INTRODUCTION
The cystatins are endogenous inhibitors of the papain-like
cysteine cathepsins and are localized mostly in the cytosol or
secreted from the cells (Turk et al., 2002; Abrahamson et al., 2003;
Kopitar-Jerala, 2006). Cysteine cathepsins are involved in pro-
tein degradation (Turk et al., 2000) and in the development and
function of the immune system (Hsing and Rudensky, 2005).
Loss-of-function mutations in the stefin B gene are found in
the patients with Unverricht-Lundborg disease (EPM1), but the
physiological function of stefin B in the molecular pathogene-
sis of the disease is not known (Lalioti et al., 1997; Pennacchio
et al., 1996). Stefin B-deficient mice display a phenotype simi-
lar to the human disease, with progressive ataxia and myoclonic
seizures (Pennacchio et al., 1998). Although, stefin B has long
been known to inhibit papain-like cathepsins in vitro by tight
and reversible binding, the physiological function of stefin B
in the molecular pathogenesis of the disease remains unknown.
Houseweart et al. showed that simultaneous deletion of cathep-
sin B and stefin B greatly reduced the neuronal apoptosis in
mice, but did not rescue the ataxia and seizure phenotypes,
Abbreviations: Ac-DEVD-AMC, acetyl-Asp-Glu-Val-Asp-AMC; AFC, 7-
amino-4-trifluoromethyl coumarin; AMC, 7-amino-4-methyl coumarin;
DMSO, dimethylsulfoxide; MTS, (3-(4,5- dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); ROS, reactive
oxygene species; STS, staurosporin; z-VAD-fmk, benzyloxycarbonyl-Val-Ala-Asp-
fmk; fmk, fluoromethyl ketone; E-64d, (2S,3S)-trans-epoxysuccinyl.
and concluded that there are other factors besides cathepsin B
that are involved in the disease pathology (Houseweart et al.,
2003). Cysteine cathepsins have been reported to contribute
to apoptosis induced by various stimuli in several cell types
(Foghsgaard et al., 2001; Stoka et al., 2001; Turk et al., 2012).
It was shown that after their release from the lysosomes, the
cathepsins cleave Bid thereby activating it and allowing it to
induce the mitochondrial release of cytochrome c and subse-
quent apoptosis (Repnik et al., 2012). However, it was demon-
strated that in stefin B-deficient mice Bid signaling is not
essential for the apoptosis in cerebellum (Houseweart et al.,
2003).
We showed that thymocytes isolated from stefin B-deficient
mice were more sensitive to staurosporin (STS)- induced
apoptosis than the wild-type thymocytes and the mechanism of
apoptosis in this particular case is independent of cathepsins and
dependent only on caspases (Kopitar-Jerala et al., 2005). In our
previous study we have identified an interaction between stefin
B and the nucleosomes, specifically with the histones H2A.Z,
H2B, and H3. In the synchronized T98G cells, stefin B co-
immunoprecipitated with histone H3, predominantly in the G1
phase of the cell cycle (Cˇeru et al., 2010). The increased expres-
sion of stefin B in the nucleus delayed cell cycle progression in
T98G cells, while stefin B-deficient mouse embryonic fibroblasts
entered the S phase earlier than the wild-type mouse embryonic
fibroblasts. The delay in cell cycle progression was associated with
Frontiers in Molecular Neuroscience www.frontiersin.org September 2012 | Volume 5 | Article 93 | 1
MOLECULAR NEUROSCIENCE
Sun et al. Stefin B expression delays caspase activation
the inhibition of cathepsin L in the nucleus, as judged from the
decreased cleavage of the CUX1 transcription factor.
The aim of our present study was to evaluate how does the
overexpression of stefin B into the nucleus influence STS-induced
apoptosis. Stefin B contains a putative 14-3-3 binding site and we
investigated whether the binding of stefin B to 14-3-3 proteins
was responsible for the delay of caspase activation. The latter are
intracellular, acidic dimeric molecules that play a role in signal
transduction pathways and apoptosis (Gardino and Yaffe, 2011).
In general, 14-3-3 proteins play a role in promoting survival and
repressing apoptosis (Morrison, 2009).
We conclude that the mechanism, by which stefin B in the
nucleus delays apoptosis, is independent of cysteine cathepsins
and 14-3-3 proteins, but we cannot exclude the possibility that
the interaction with histones, or specific histone variants are
important for the process.
MATERIALS AND METHODS
CELL CULTURE
T98G human glioblastoma cell line, ATCC CRL-1690, was from
the American Type Culture Collection (Manassas, VA). Cells were
cultured as described previously (Cˇeru et al., 2010) T98G cells
were transfected with pEF/Myc/Nuc/stefin B named NB or empty
pEF/Myc/Nuc vector alone named NO, using Lipofectamine
2000 (Invitrogen), according to the manufacturer’s instructions.
Positive clones overexpressing stefin B in the nucleus were
obtained after selection with Geneticin (G418) (Invitrogen), as
described before (Cˇeru et al., 2010).
BRIGHT FIELD MICROSCOPY
T98G cells were grown in DMEM, 10% FCS, and 2mM
l-glutamine in 6-well culture plates at 5 × 106 cells/well. The
cell-permeable inhibitors E-64d (Peptide Institute, Osaka,
Japan), or z-VAD-fmk (Bachem AG, Switzerland) were added
in adequate concentrations in dimethylsulfoxide (DMSO) 1 h
prior to induction of apoptosis. The corresponding volume
of DMSO was added to the control cultures. To induce apop-
tosis, cells were treated 500 nM STS for 5 h. Live and death
cells were determined with an Olympus IX81 microscope
(Olympus, Japan) and by MTS (3-(4,5- dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
viability assay.
MTS REDUCTION ASSAY
Cell viability was assayed by MTS viability assay (Promega,
Fitchburg, WI), essentialy as described previously (Anderluh
et al., 2005). The T98G cells were plated on to 96-well plates at
a density of 104 cells/well in 100μL DMEM medium. The cell-
permeable inhibitors E-64d (Peptide Institute, Osaka, Japan), or
z-VAD-fmk (Bachem AG, Switzerland) were added in adequate
concentrations in DMSO 1 h prior to induction of apoptosis.
The corresponding volume of DMSO was added to the control
cultures. Cell death was induced wih 500mM STS. Twenty micro-
liters of MTS reagent was then added to each well. The plate
was incubated for 2–3 h at 37◦C in a 5% (v/v) CO2 humidified
environment. Four independent experints were performed in
triplicates. The absorbance of formazan was measured at 490 nm.
MEASUREMENT OF DEVD-ase ACTIVITY
Fifty micrograms samples of protein from control and
STS-treated cells, in the presence or absence of inhibitors,
were used to determine caspase activity by measuring pro-
teolytic cleavage of the fluorogenic substrate Ac-DEVD-
trifluoromethylcoumarin (Bachem), as described (Kopitar-Jerala
et al., 2005).
PREPARATIONOF CELL LYSATES ANDWESTERN BLOTS
Cell lysates were prepared as described (Kopitar-Jerala et al.,
2005). The cell lysates were transferred to fresh test tubes and,
if not used immediately, stored at −80◦C. Total protein con-
centration was determined using the Bradford assay (Bio-Rad).
Western blots were performed as described (Kopitar-Jerala et al.,
2005). Equal amounts of protein were loaded and resolved in
15 or 12.5% SDS-PAGE gels and electrotransferred to nitrocellu-
lose membranes. Proteins were visualized with ECL (Amersham)
according to the manufacturer’s instructions. All immunoblots
were probed with actin to confirm equal protein loading.
STATISTICAL ANALYSIS
Data are presented as mean ± S.D. Statistical differences among
groups were evaluated by the Student t-test. Differences were
considered significant for P < 0.005.
RESULTS
STS-INDUCED APOPTOSIS T98G CELLS IS CASPASE-DEPENDENTAND
CATHEPSIN-INDEPENDENT
We first confirmed that STS-induced apoptosis in T98G cells
follows the same mechanism as STS-induced apoptosis in thy-
mocytes (Kopitar-Jerala et al., 2005). In our previous exper-
iments we determined the dose response curve of STS on
T98G cells, and used 500 nM STS. Treatment of T98G astrocy-
toma cells with 500 nM STS for 9 h resulted in detachment of
cells from the culture dishes and major morphological changes,
such as considerable cell shrinkage and rounding (Figure 1).
All of the morphological changes were substantially prevented
by pretreatment of cells with the pan-caspase inhibitor Z-VAD-
fmk (25μM), but not with the general inhibitor of cysteine
cathepsins E-64d (25μM) indicating that STS-induced apotosis
in T98G cells is caspase-dependent and cathepsin-independent
(Figure 1).
Decrease in cell viability after STS treatment and pretreat-
ment with the inhibitors was determined quantitatively using the
MTS assay, as described (Anderluh et al., 2005). T98G cells were
treated with STS in the presence or the absence of the pan-caspase
inhibitor z-VAD-fmk or E-64d. In T98G cells z-VAD-fmk inhib-
ited cell death, while E-64d did not have any effect on cell survival
(Figure 2).
EXPRESSIONOF STEFIN B IN THE NUCLEUS DELAYED CASPASE
ACTIVATION
Next, we examined whether overexpression of stefin B in the
nucleus influences STS-induced apoptosis. T98G cells were
transfected with a pEF/Myc/Nuc vector expressing stefin B
pEF/Myc/Nuc-stefin B (NB), or an empty vector alone (NO)
as described (Cˇeru et al., 2010). We followed the time
Frontiers in Molecular Neuroscience www.frontiersin.org September 2012 | Volume 5 | Article 93 | 2
Sun et al. Stefin B expression delays caspase activation
FIGURE 1 | Representative images of T98G cells after 5h of incubation
with 500nM STS. Following treatment with 500nM STS cells shrunk,
rounded, and detached from the surface as seen by light microscopy
(A) untreated cells (B) cells treated with 500nM STS. The majority of these
morphological changes were prevented by Z-VAD-fmk (C), but not by
E-64d (D). Bar 200μM.
FIGURE 2 | T98G cell viability upon STS treatment. MTS assays were
performed to measure the T98G cell viability after STS treatment. Data are
expressed by the mean of percent cell viability compared to control after
exposure for 9 h ± standard deviation. The cell-permeable inhibitors E-64d
or z-VAD-fmk were added in adequate concentrations in DMSO 1h prior to
induction of apoptosis. The corresponding volume of DMSO was added to
the control cells. Cell death was induced wih 500mM STS. The data are
representative of three independent experiments. Statistical significance
was analyzed by the Student’s t-test. A P -value ≤ 0.001 (∗∗∗) was
considered significant.
course of apoptosis with regard to caspase activation and cell
viability testing. Examination of the time-dependent activation
of DEVD-ase activity induced by STS revealed that DEVD-ase
activity began to increase approximately 5 h after STS treatment
and reached a maximum after 9 h. Five hours after addition of
STS a significantly faster caspase activation was observed in the
control T98G cells and T98G cells with increased expression of
FIGURE 3 | DEVD-ase activities in the cell lysates. T98G cells
transfected with an empty vector (pcDNA3 vector), T98G cells
overexpressing stefin B in the cytosol (pcDNA3-stefin B) and in the nucleus
(NucMyc-stefin B), together with a control empty vector pEF/myc/nuc
(NucMyc-Vector) were treated with 500nM STS. DEVD-ase activities were
determined after 5 h (A) and 9h (B) of incubation, as described in Materials
and Methods. Results are means ± S.D. of at least three independent
experiments performed in triplicate.
stefin B into cytosol, but not NB cells overexpressing stefin B
into nucleus (Figure 3A). Nine hours after the addition of STS,
the DEVD-ase activity was increased in NB cells, while in the
other control cell lines it was already lower than at the 5 h time
point (Figure 3B). The same was observed both in T98G tran-
siently transfected cells, and in the stable cell lines obtained after
G418 selection. Apoptotic cell death was additionally confirmed
with Western blotting of caspase-7 activation (Figure 4). Since
apoptosis is cathepsin-independent, we reasoned that the non-
inhibitory functions of stefin B are responsible for the effect we
observed.
INCREASED EXPRESSION OF STEFIN B IN THE NUCLEUS OR CYTOSOL
DID NOT PREVENT PARP CLEAVAGE BY CASPASES
Poly(ADP-ribose) polymerase (PARP) is a well defined substrate
of caspases during the apoptosis. Since the increased expression of
stefin B in the nucleus, but not in the cytosol, delayed caspase acti-
vation, we examined the cleavage of a nuclear caspase substrate
Poly(ADP-ribose) polymerase (PARP). Using specific antibodies
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FIGURE 4 | Caspase-7 activation during STS-induced apoptosis in
T98G cells. Equal amounts of proteins (70μg) were loaded and separated
on 12,5% SDS-PAGE, followed by Western blotting with anti-caspase-7
monoclonal antibody F5/1 (Gregorc et al.). Membranes were stripped and
re-developed with anti-actin Ab. Track 1: control (untreated cells); 2: T98G
cells; track 3: T98G with an empty vector pcDNA3, track 4: T98G cells
overexpressing stefin B into the cytosol; track 5: T98G cells overexpressing
stefin B into the nucleus (NB); track 6: control cells transfected with an
empty pEF/myc/nuc vector (NO). The data represent the mean of
triplicate data points ± S.E. and are representative of three independent
experiments. The data are representative of three independent
experiments.
FIGURE 5 | Caspase substrate PARP cleavage was detected after STS
treatment in T98G cells and T98G cells transfected with stefin B. An
equal amount of proteins (70μg) was loaded and separated on 12,5%
SDS-PAGE, followed by Western blotting with the anti-PARP antibody.
Membranes were stripped and re-developed with anti-actin Ab. Track 1:
control (untreated cells); track 2: T98G cells; track 3: T98G with an empty
vector pcDNA3, track 4: T98G cells overexpressing stefin B into cytosol;
track 5: T98G cells overexpressing stefin B into nucleus; track 6: control
cells transfected with an empty pEF/myc/nuc vector.
we detected the specific PARP fragment (85 kDa) generated by the
caspases in the T98G cell lysates prepared 5 h after the induction
of apotosis (Figure 5). However, we could not confirm any signif-
icant differences between PARP cleavage in the control cells and
in the cells overexpressing stefin B in the nucleus or in the cytosol
(Figure 5).
STEFIN B DOES NOT INTERACTWITH 14.3.3 PROTEINS
The stefin B amino acid sequence contains the conventional bind-
ing motif that is present in most 14-3-3 binding proteins, and
is also conserved in several stefin B species variants (Figure 6).
FIGURE 6 | Stefin B species variants contain putative 14-3-3 binding
site.
We investigated if the interaction of stefin B with 14-3-3 proteins
is important for the delay of apoptosis observed in the T98G cells
with increased nuclear expression of stefin B. However, the inter-
action of stefin B with 14-3-3 proteins could not be confirmed
by co-immuno precipitations neither in the cytosolic nor in the
nuclear extracts (data not shown), suggesting that the delay in
caspase activation and apoptosis in s not due to the interactions
of stefin B with 14-3-3 proteins.
DISCUSSION
The results of our study provide a new insight into the regulation
of cell death by stefin B, a nuclear and cytosolic inhibitor of cys-
teine cathepsins. It has been shown that the increased expression
of stefin B in the nucleus, but not in the cytosol, only delays
caspase activation and apotosis, but did not prevent cell death.
STS activates the intrinsic apoptotic pathway, it induces mito-
chondrial outer membrane permeabilization, which is followed
by the release of cytochrome c and the downstream activation
of caspases (Duan et al., 2003). Cells from mice lacking both
Bax and Bak are completely resistant to STS, as well as several
other apoptotic stimuli that act through disruption of mito-
chondrial function (Wei et al., 2001). Moreover, recent studies
demonstrated that the cathepsins, when released from the lyso-
somes degrade not only Bid, but also the antiapoptotic Bcl-2
family members Bcl-2, Bcl-xL, and Mcl-1, thereby also trig-
gering the mitochondrial apoptotic pathway (Droga-Mazovec
et al., 2008). Several reports showed that lysosomal cysteine
cathepsins, in particular cathepsin B, participate also in the
extrinsic apototic parhway induced by the Tumor necrosis fac-
tor (TNF)-related apoptosis-inducing ligand (TRAIL) (Nagaraj
et al., 2006; Werneburg et al., 2007). TRAIL induces apopto-
sis by binding to two death receptors TRAIL-R1 and TRAIL-
R2. This leads to the recruitment of the adaptor protein,
Fas-associated death domain (FADD), which in turn recruits
the initiator caspase, caspase-8, which is activated by auto-
proteolytic cleavage, leading to the activation of downstream
effector caspases and cell death (Pop et al., 2007). In addi-
tion, stefin B was also suggested to contribute to the resis-
tance of melanoma cells to TRAIL-induced apoptosis, however,
the inhibition of cathepsins L and B was found not to be
important in this process, and stefin B was suggested partici-
pate in the process by preventing the proteasomal degradation
of FLIPL, by an yet undefined mechanism (Yang et al., 2010).
Leist and Jäättelä suggested that the cathepsins can mediate also
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caspase-independent apoptosis (Leist and Jäättelä, 2001), but in
the present study we demonstrated that STS-induced apoptosis
in T98G cell was completely independent of cysteine cathepsins
and dependent only on the caspases. Our findings are in agree-
ment with the proposal that the cathepsins predominantly trigger
the caspase-dependent cell death (Repnik et al., 2012).
Another potential mechanism, by which stefin B could con-
tribute to the delayed STS-induced apoptosis are reactive oxygen
species (ROS). It was reported that STS-induced apoptosis leads
also to the generation of ROS (Ricci et al., 2004). Moveover, it
was shown that stefin B deficiency sensitizes cerebellar granule
neurons to oxidative stress-induced cell death (Lehtinen et al.,
2009). It could be therefore expected that overexpression of stefin
B in the cytosol would protect the cells from the ROS-induced
cell death. However, we did not detect any significant difference
in caspase activity in cells with increased expression of stefin B
in cytosol and in the control cells. We can conclude that at least
in the system used, ROS did not play a major role in caspase
activation.
Another potential link between apoptosis and stefin B present
also the proteins from 14-3-3 family. STS inhibits several pro-
tein kinases, however, it has the highest affinity for the protein
kinase C (PKC) isoenzymes (Tamaoki et al., 1986). Recent reports
have shown that 14-3-3 proteins function as a PKC regulators
(Saurin et al., 2008). While 14-3-3 proteins often interact with
the phosphoserine or phosphothreonine residues in their lig-
ands, they can also interact with some ligands, including human
telomerase (Seimiya et al., 2000) and the amyloid beta-protein
precursor intracellular domain fragment (Sumioka et al., 2005),
in a phosphorylation-independent manner. Although stefin B
contains a putative 14-3-3 binding site, the interaction of stefin
B with 14-3-3 proteins was not detected in the cytosol or in the
nucleus.
However, we cannot exclude the possibility that the inter-
action of stefin B with histones, or specifically with modified
histones, could be responsible for the delay in caspase activation.
Histones can be covalently modified by several post-translational
modifications including acetylation, methylation, phosphoryla-
tion, and ubiquitination (Kouzarides, 2007). These modifications
occur mainly in the amino-terminal tail of the histones, but can
also occur in the globular domain. The “histone code” hypoth-
esis proposes that specific histone modifications regulate gene
expression by either changing the chromatin structure into an
“activated” or “repressed” transcriptional state, or by acting as
a docking site for transcriptional regulators that associate with
chromatin (Jenuwein and Allis, 2001; Loyola and Almouzni,
2007). We have reported that stefin B is associated with H2A.Z
and H3K4Me3 histone variant (Cˇeru et al., 2010). H2A.Z vari-
ant was found in the promoter regions associated with regulatory
elements (Barski et al., 2007). It has been further suggested
that H2A.Z deposition and H3K4me3 modification may facilitate
nucleosome eviction or repositioning in promoter regions of the
human genes (Schones et al., 2008). H3K4me3 histone modifi-
cation has been shown to facilitate pre-mRNA maturation (Sims
et al., 2007), implying a possible role for stefin B in this process.
In conclusion, we have shown that stefin B overexpression in
the nucleus delayed not only cell cycle progression, as reported
before, but also caspase activation. Whereas the main reason for
the delayed cell cycle progression is probably the decreased CUX1
cleavage, the mechanism by which nuclear stefin B delays caspase
activation is not clear yet. Stefin B was thus shown not to inter-
fere with ROS signaling nor to interact with the 14-3-3 proteins,
which regulate the PKC function. One of the possibilities remain
the stefin B interaction with the histones. However, additional
studies will be needed to reveal the mechanism by which nuclear
stefin B delays caspase activation.
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